113 related articles for article (PubMed ID: 26212011)
1. Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer.
Timsah Z; Ahmed Z; Ivan C; Berrout J; Gagea M; Zhou Y; Pena GN; Hu X; Vallien C; Kingsley CV; Lu Y; Hancock JF; Liu J; Gladden AB; Mills GB; Lopez-Berestein G; Hung MC; Sood AK; Bogdanov M; Ladbury JE
Oncogene; 2016 Apr; 35(17):2186-96. PubMed ID: 26212011
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
[TBL] [Abstract][Full Text] [Related]
3. Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion.
Timsah Z; Ahmed Z; Lin CC; Melo FA; Stagg LJ; Leonard PG; Jeyabal P; Berrout J; O'Neil RG; Bogdanov M; Ladbury JE
Nat Struct Mol Biol; 2014 Feb; 21(2):180-8. PubMed ID: 24440983
[TBL] [Abstract][Full Text] [Related]
4. FGFR and PTEN signaling interact during lens development to regulate cell survival.
Chaffee BR; Hoang TV; Leonard MR; Bruney DG; Wagner BD; Dowd JR; Leone G; Ostrowski MC; Robinson ML
Dev Biol; 2016 Feb; 410(2):150-163. PubMed ID: 26764128
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma.
Timsah Z; Berrout J; Suraokar M; Behrens C; Song J; Lee JJ; Ivan C; Gagea M; Shires M; Hu X; Vallien C; Kingsley CV; Wistuba I; Ladbury JE
Am J Cancer Res; 2015; 5(10):3135-48. PubMed ID: 26693065
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
Lau MT; Klausen C; Leung PC
Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
[TBL] [Abstract][Full Text] [Related]
9. Grb2 binds to PTEN and regulates its nuclear translocation to maintain the genomic stability in DNA damage response.
Hou B; Xu S; Xu Y; Gao Q; Zhang C; Liu L; Yang H; Jiang X; Che Y
Cell Death Dis; 2019 Jul; 10(8):546. PubMed ID: 31320611
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma.
Abe A; Minaguchi T; Ochi H; Onuki M; Okada S; Matsumoto K; Satoh T; Oki A; Yoshikawa H
Hum Pathol; 2013 Feb; 44(2):199-207. PubMed ID: 22955107
[TBL] [Abstract][Full Text] [Related]
11. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
12. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
13. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
Yang H; Kong W; He L; Zhao JJ; O'Donnell JD; Wang J; Wenham RM; Coppola D; Kruk PA; Nicosia SV; Cheng JQ
Cancer Res; 2008 Jan; 68(2):425-33. PubMed ID: 18199536
[TBL] [Abstract][Full Text] [Related]
15. Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function.
Ahmed Z; George R; Lin CC; Suen KM; Levitt JA; Suhling K; Ladbury JE
Cell Signal; 2010 Jan; 22(1):23-33. PubMed ID: 19735729
[TBL] [Abstract][Full Text] [Related]
16. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
[TBL] [Abstract][Full Text] [Related]
17. Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.
Chun SH; Jung CK; Won HS; Kang JH; Kim YS; Kim MS
Head Neck; 2015 May; 37(5):636-43. PubMed ID: 24616007
[TBL] [Abstract][Full Text] [Related]
18. [Effects of PTEN over-expression on phosphatidyl inositol 3-kinase/protein kinase B signal pathway in ovarian epithelial cancer cells].
Zhai YN; Xu LL; Shen Y; Xia H; Shen YF
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):682-5. PubMed ID: 21092549
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of basal FGF receptor signaling by dimeric Grb2.
Lin CC; Melo FA; Ghosh R; Suen KM; Stagg LJ; Kirkpatrick J; Arold ST; Ahmed Z; Ladbury JE
Cell; 2012 Jun; 149(7):1514-24. PubMed ID: 22726438
[TBL] [Abstract][Full Text] [Related]
20. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
